LGALS3 and hydrops fetalis: The main finding of our study was that Gal-3 demonstrated a good prognostic value in predicting in-hospital new-onset HF in patients with a first STEMI or NSTEMI successfully treated with primary percutaneous coronary intervention (pPCI).